By Lawrence Hurley WASHINGTON (Reuters) - Generic drug manufacturers on Monday asked the U.S. Supreme Court to allow a lower court ruling favoring them to take effect while the high court considers an appeal in a patent fight over Teva Pharmaceutical Industries Ltd's top-selling multiple sclerosis drug, Copaxone. Novartis AG's Sandoz Inc, Momenta Pharmaceuticals Inc, Mylan Inc and Natco Pharma Ltd were responding to a stay application made by Teva to Chief Justice John Roberts last week. The Supreme Court could now announce at any time whether it will grant the request.
via Health News Headlines - Yahoo News http://ift.tt/1hP4lLC
via Health News Headlines - Yahoo News http://ift.tt/1hP4lLC
No comments:
Post a Comment